The mission of the Good CME Practice group is to promote professionalism within the European CME provider community.
It achieves this by championing high standards in the development and delivery of CME in Europe through collaboration with critical stakeholders.
gCMEp aims to enhance the competence of CME providers in order to deliver high quality independent education for healthcare professionals with the ultimate aim of improving health outcomes.
The Good CME Practice group (gCMEp) is a membership organisation for European continuing medical education (CME) providers. The Group is an initiative of the European CME Forum, which has a wider stakeholder base.
The degree of importance attached to robust and relevant CME in Europe continues to grow. Many countries are developing regulations, accreditation schemes or guidelines to encourage participation in continuing medical education and thus improve clinical practice and outcomes.
Consequently there is a clear need for ensuring that accredited activities:
- are developed by independent, qualified, scientific educators
- meet identified participant needs
- are free from bias and
- are of high quality.
CME stakeholders are increasingly working together to understand each others’ positions and share best practice. Industry is re-examining their expenditure in this field as a result of increasing regulatory and public pressure primarily focused on perceptions on bias. Financial pressures are becoming evident with the profession and health systems evaluating how education is to be funded, while industry in Europe looks for transparent and credible ways to support CME activities in a positive way.
Find out more about the gCMEpJoin now
November 2019 Good CME Practice group members lead two sessions at the 12th Annual European CME Forum in Manchester, UK.
November 2019 Good CME Practice group co-author of the Position Paper “Regulating for Bias in Medical Education – Reaction to the Pharmaceutical Industry Updated EFPIA Code of Practice” published in JECME, calling for more detailed guidance for Pharma when supporting independent medical education.